In an effort to further elucidate the expression patterns of SHP2 in a clinical context, we conducted protein expression analysis in KRAS wild‐type and mutant tissues within LUAD and lung squamous cell carcinoma (LUSC) from the TCGA database. The gene discussed is KRAS; the disease is squamous cell lung carcinoma.